Source comparison
TB-4 vs TB-500: Pros and Cons
Source Natural human protein Synthetic fragment Molecular Size Larger, complex Smaller, more stable Bioavailability Lower when injected or applied topically Higher tissue penetration Regulatory Status Experimental, limited human trials Unapproved, off-label us
This comparison does not assign a generated winner or score.
- Source
- Natural human protein
- Synthetic fragment
- Molecular Size
- Larger, complex
- Smaller, more stable
- Bioavailability
- Lower when injected or applied topically
- Higher tissue penetration
- Regulatory Status
- Experimental, limited human trials
- Unapproved, off-label use
- Cost
- Typically higher
- Generally lower than full TB-4
- Clinical Evidence
- Sparse, mostly animal studies
- Sparse, mostly anecdotal or animal
- Neither is FDA-approved for injury repair. Most human data come from small trials or case reports, so certainty about safety and efficacy is limited.